Spots Global Cancer Trial Database for erlotinib [tarceva]
Every month we try and update this database with for erlotinib [tarceva] cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer | NCT00940875 | Non-Small Cell ... | erlotinib [Tarc... gemcitabine gemcitabine | 18 Years - | Hoffmann-La Roche | |
| A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. | NCT00531934 | Non-Small Cell ... | Doxycline erlotinib [Tarc... | 18 Years - 75 Years | Hoffmann-La Roche | |
| A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). | NCT00760929 | Non-Squamous No... | Placebo Placebo RG1507 RG1507 erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00883779 | Non-Squamous No... | Placebo Platinum chemot... erlotinib [Tarc... gemcitabine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations | NCT01609543 | Non-Squamous No... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN) | NCT01204697 | Non-Squamous No... | docetaxel erlotinib [Tarc... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT01996332 | Non-Small Cell ... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer | NCT01196078 | Non-Small Cell ... | erlotinib [Tarc... vinorelbine | 70 Years - | Hoffmann-La Roche | |
| A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). | NCT00760929 | Non-Squamous No... | Placebo Placebo RG1507 RG1507 erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis | NCT00800202 | Non-Small Cell ... | bevacizumab [Av... carboplatin erlotinib [Tarc... paclitaxel | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | NCT01183858 | Non-Small Cell ... | Erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT00556322 | Non-Small Cell ... | Alimta or Taxot... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | NCT00925769 | Pancreatic Canc... | bevacizumab [Av... capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | NCT00718315 | Non-Small Cell ... | erlotinib [Tarc... fusidic acid [V... erythromycin [E... Fisiogel | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy | NCT02013206 | Non-Small Cell ... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT00556322 | Non-Small Cell ... | Alimta or Taxot... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | NCT00811993 | Neoplasms | RG1507 RO1507 bevacizumab [Av... capecitabine [X... carboplatin cetuximab docetaxel erlotinib [Tarc... etoposide gemcitabine irinotecan mFOLFOX6 paclitaxel pemetrexel sorafenib temozolomide trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. | NCT00773383 | Non-Small Cell ... | RG1507 erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations | NCT01287754 | Non-Small Cell ... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer | NCT01066884 | Non-Squamous No... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer | NCT02031744 | Non-Small Cell ... | erlotinib [Tarc... Placebo Onartuzumab [Me... | 18 Years - | Hoffmann-La Roche | |
| A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer | NCT02031744 | Non-Small Cell ... | erlotinib [Tarc... Placebo Onartuzumab [Me... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | NCT01998919 | Non-Small Cell ... | erlotinib [Tarc... placebo gemcitabine cisplatin carboplatin | 18 Years - | Hoffmann-La Roche | |
| A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients. | NCT01250119 | Non-Squamous No... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations | NCT01609543 | Non-Squamous No... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | NCT01183858 | Non-Small Cell ... | Erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy | NCT02013206 | Non-Small Cell ... | erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
